Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-09-17
2010-06-22
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S309000, C544S128000, C546S141000
Reexamination Certificate
active
07741322
ABSTRACT:
The present invention relates to compounds having the structure (I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
REFERENCES:
patent: 3594380 (1971-07-01), Sulkowski et al.
patent: 0 585 913 (1993-09-01), None
patent: 0 634 401 (1994-07-01), None
patent: WO 02/24655 (2002-03-01), None
patent: WO 02 094790 (2002-11-01), None
Natsugari, et al., Novel, Potent, and Orally Active Substance P Antagonists: Synthesis and Antagonist Activity of N-Benzylcarboxamide Derivatives of Pyrido[3,4-b]pyridine, 1995, 3106-2120, v38, J. Med. Chem.
Bergman Jeffrey M.
Claremon David A.
Dinsmore Christopher J.
Isaacs Richard
McIntyre Charles J.
Daniel Mark R.
Davis Zinna N.
Merck Sharp & Dohme Corp.
Parr Richard S.
Struse Heidi M.
LandOfFree
Isoquinolinone potassium channel inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoquinolinone potassium channel inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinolinone potassium channel inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4191971